We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
-17.4%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.13B
AUM Growth
-$27.7M
Cap. Flow
+$215M
Cap. Flow %
18.92%
Top 10 Hldgs %
6.33%
Holding
1,227
New
318
Increased
332
Reduced
244
Closed
300

Top Buys

Rank Stock Value
1
CVNA icon
Carvana
CVNA
+$6.3M
2
HON icon
Honeywell
HON
+$6.1M
3
FICO icon
Fair Isaac
FICO
+$5.7M
4
USFD icon
US Foods
USFD
+$5.48M
5
BC icon
Brunswick
BC
+$5.2M

Top Sells

Rank Stock Value
1
ARCH
Arch Resources, Inc.
ARCH
+$6.65M
2
QLYS icon
Qualys
QLYS
+$6.64M
3
EOG icon
EOG Resources
EOG
+$5.88M
4
SPGI icon
S&P Global
SPGI
+$5.29M
5
MSCI icon
MSCI
MSCI
+$5.23M

Sector Composition

Rank Sector Weight
1 Technology 20.97%
2 Healthcare 18.41%
3 Industrials 13.29%
4 Consumer Discretionary 11.36%
5 Financials 11.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VERX icon
676
Vertex
VERX
$2.15B
$388K 0.03%
34,284
-7,161
-17% -$90.6K
GBIO
677
DELISTED
Generation Bio
GBIO
$382K 0.03%
5,816
-3,746
-39% -$245K
CGBD icon
678
Carlyle Secured Lending
CGBD
$716M
$381K 0.03%
30,039
-4,481
-13% -$62.9K
MAR icon
679
Marriott International
MAR
$99.6B
$381K 0.03%
+2,800
New +$463K
ZETA icon
680
Zeta Global
ZETA
$5.39B
$381K 0.03%
+84,362
New +$740K
PRK icon
681
Park National Corp
PRK
$3.71B
$380K 0.03%
+3,135
New +$377K
RGNX icon
682
Regenxbio
RGNX
$603M
$380K 0.03%
15,385
+1,360
+10% +$34K
PRTS icon
683
CarParts.com
PRTS
$42.1M
$378K 0.03%
5,440
-14,657
-73% -$1.07M
CWAN
684
DELISTED
Clearwater Analytics
CWAN
$377K 0.03%
+31,343
New +$507K
OLMA icon
685
Olema Pharmaceuticals
OLMA
$985M
$376K 0.03%
92,354
-30,004
-25% -$95.2K
VVNT
686
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
$374K 0.03%
107,603
+81,580
+313% +$435K
HAE icon
687
Haemonetics
HAE
$3.76B
$372K 0.03%
5,703
-17,850
-76% -$1.06M
PRVB
688
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$372K 0.03%
93,009
TVRD
689
Tvardi Therapeutics
TVRD
$22.7M
$371K 0.03%
1,128
-2,025
-64% -$710K
BTAI icon
690
BioXcel Therapeutics
BTAI
$25.9M
$370K 0.03%
1,752
FBMS
691
DELISTED
The First Bancshares, Inc.
FBMS
$370K 0.03%
12,947
+5,152
+66% +$160K
DCGO icon
692
DocGo
DCGO
$61.5M
$369K 0.03%
+51,749
New +$377K
AKRO
693
DELISTED
Akero Therapeutics
AKRO
$367K 0.03%
+38,872
New +$405K
SANM icon
694
Sanmina
SANM
$9.07B
$367K 0.03%
+9,019
New +$373K
UCTT
695
Ultra Clean Holdings
UCTT
$3.49B
$367K 0.03%
+12,327
New +$400K
PD icon
696
PagerDuty
PD
$801M
$365K 0.03%
+14,723
New +$404K
B
697
DELISTED
Barnes Group Inc.
B
$365K 0.03%
+11,707
New +$408K
SRRK icon
698
Scholar Rock
SRRK
$5.82B
$360K 0.03%
+65,645
New +$472K
GMED icon
699
Globus Medical
GMED
$10.8B
$359K 0.03%
6,400
-5,871
-48% -$386K
ALEC icon
700
Alector
ALEC
$168M
$357K 0.03%
35,160
+7,464
+27% +$74.4K

Similar funds

PDT Partners's Q2 2022 Portfolio in Review

As of Q2 2022, PDT Partners held 1,227 positions worth $1.13B, down 2.4% from $1.16B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.

PDT Partners deployed $215M of net new capital in Q2 2022, opening 318 new positions and adding to 332 existing holdings. Its largest new stake was Honeywell: 33,974 shares worth $5.57M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Arch Resources, Inc., an estimated $6.65M trimmed.

  • PDT Partners's largest Q2 2022 buy was Honeywell: 33,974 shares worth $5.57M.
  • PDT Partners added most to Carvana in Q2 2022, an estimated $6.3M increase.
  • PDT Partners's biggest Q2 2022 reduction was Arch Resources, Inc., cutting an estimated $6.65M.
  • PDT Partners fully exited Qualys in Q2 2022, selling an estimated $6.64M.
  • PDT Partners's ten largest holdings make up 6.3% of its $1.13B portfolio in Q2 2022.
  • PDT Partners opened 318 new positions and closed 300 in Q2 2022.
  • PDT Partners's portfolio value fell 2.4% quarter-over-quarter to $1.13B.

Based on PDT Partners's 13F filing for Q2 2022, filed 15 Aug 2022.